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Tuesday, October 26, 2021 
 
 
During this COVID-19 pandemic and other future events, the CDM has been 
and will continue to be a source of reliable information, education and models 
for mitigation, preparedness, response, and recovery.  We hope this 
informational document has helped provide you filtered and actionable 
information.  As the pace of new information and changes occur, we will 
evaluate the current once per week to determine if this information should be 
provided on a more frequent basis.   
 
 
                                                                                                                        
David Markenson, M.D., M.B.A. 
Director 









 Total Cases Total Deaths Total Vaccine 
Doses Admin. 
Worldwide 244,054,440 4,954,527 6,833,629,924 
United States 45,544,971 737,316 412,604,550 
New Jersey 1,189,496 27,851 12,244,787 
New York 2,533,155 56,222 27,199,492 
Connecticut 400,226 8,739 5,310,937 
 
Information as of 10/26/21 at 0100 EDT. Source: https://coronavirus.jhu.edu/map.html  
 
 





Center for Disaster Medicine Updates 
 
 
• On October 20, 2021, Center for Disaster Medicine staff provided important National 
Association of Emergency Medical Technicians (NAEMT) Prehospital Trauma Life Support 
(PHTLS) training to members of emergency services in New York State from as far as 
Mohawk, New York, to as local as Ossining. Emergency Medical Technicians (EMTs and 
paramedics) from Ossining, Empress EMS, Yonkers Police, American Medical Response, 
Mohawk Valley Ambulance Corps and Valhalla Volunteer Ambulance Corps participated in 
this 16-hour course. The training focused on managing life-threatening trauma emergencies 
in the prehospital environment.  Using high fidelity simulation and other modalities, the 
students received incredible realism to better prepare them for future emergencies.   
• Coordinating and overseeing COVID-19 screenings at NYMC campus 
• Continue to partner with local organizations such as Westchester Department of Emergency 
Services and Westchester Medical Center to ensure ongoing collaboration with all public 
safety agencies. 
• Coordinating volunteers to support local public health response to COVID-19. 
• Conducting research and analysis of current events and COVID-19 response to identify 
strengths and areas for improvement in other regions. 
• Updating and developing new programs to provide enhanced education on public health 
emergencies including pandemics. 
• Exploring course development opportunities in infection prevention and control for frontline 
responders in the hospital and in the field. 
• Serving as a source of information for COVID-19 related concerns or questions regarding 
public health, emergency medical service (EMS), public safety and healthcare response. 
• Local networking and pandemic response analysis for New York’s tri-state area, using first-
person experiences to highlight current trends. 
 
To view the Center for Disaster Medicine's newest webinar, please click here - The 





• As of October 22, 2021, the Department of Veterans Affairs is offering Moderna and 
Johnson & Johnson (J&J)/Janssen COVID-19 vaccine booster shots under Emergency 
Use Authorization, expanding on last month’s authorization of the Pfizer-BioNTech 
booster. “Booster shots are an important step forward in the fight against COVID-19,” 
said VA Secretary Denis McDonough. “With the authorization of additional COVID-19 
vaccine booster options, VA is helping more Veterans maximize their protection, 
continuing our work to keep people safe and save lives during the COVID-19 pandemic.” 
https://www.va.gov/opa/pressrel/pressrelease.cfm?id=5732 
 
The White House 
 
On October 25, 2021, Background Press Call by Senior Administration Officials on COVID-⁠19 
and International Air Travel Policy- Senior officials announced an important step forward in 
operationalizing this new system as it relates to international air travel by releasing a series of 
documents that will help airlines and travelers get ready for November 8 and ensure a smooth 




On October 25, 2021, a proclamation on advancing the safe resumption of global travel during 
the COVID-⁠19 pandemic- The continued spread of the SARS-CoV-2 virus that causes 
coronavirus disease 2019 (COVID-19) is a global threat to our health and safety.  COVID-19 has 
resulted in more than 733,000 deaths in the United States and more than 4,932,000 deaths 
worldwide.  New variants of SARS-CoV-2 have also emerged globally, and variants that are 
more transmissible or cause more severe disease than the original virus strain are identified by 




On October 22, 2021, the White House COVID-⁠19 Response Team and Public Health Officials 
provided a press briefing to discuss the latest updates including plans for Pfizer vaccines for 




The official website of the White House will deliver updated information as the country grapples 
with converging crises. This will include actions to control the COVID-19 pandemic, provide 
economic relief, tackle climate change, and advance racial equity and civil rights, as well as 
immediate actions to reform our immigration system and restore America’s standing in the world. 









United States Food and Drug Administration (FDA) 
 
As of October 22, 2021, 419 tests and sample collection devices are authorized by the 
FDA under emergency use authorizations (EUAs). These include 292 molecular tests and 
sample collection devices, 89 antibody and other immune response tests and 38 antigen 
tests. There are 66 molecular authorizations and one antibody authorization that can be 
used with home-collected samples. There is one molecular prescription at-home test, 
three antigen prescription at-home tests, nine antigen over-the-counter (OTC) at-home 
On October 22, 2021, HHS Invests more than $560 million to Bolster Product Manufacturing to 
Increase Supply, Availability of COVID-19 Tests- As the Administration works to vaccinate the 
population, in the past several weeks the Biden Administration, through the Department of 
Health and Human Services (HHS), has invested more than half a billion dollars from the 
American Rescue Plan to boost manufacturing of key products needed to increase domestic 
testing supply. These investments are an integral part of the Administration’s strategy to expand 
COVID-19 testing and make tests more widely available for Americans as we work to slow the 








National Institutes of Health (NIH)  
 
COVID vaccine booster increases antibody responses, is protective in rhesus macaques- A 
booster dose of the mRNA-1273 COVID-19 vaccine given to rhesus macaques about six months 
after their primary vaccine series significantly increased levels of neutralizing antibodies against 
all known SARS-CoV-2 variants of concern, according to a new study from National Institutes of 
Health scientists and colleagues. The study, published in I also showed that the increased 
neutralizing antibody responses were sustained for at least eight weeks after the boost, were 
significantly higher than after the primary vaccine series, and generated high-level protection – 
meaning the ability to significantly limit virus from replicating in the lungs and nose. These data 





View the latest COVID-19 information from NIH 
https://www.nih.gov/coronavirus  
 
tests and two molecular OTC at-home tests. The FDA has authorized 16 antigen tests 
and eight molecular tests for serial screening programs. The FDA has also authorized 657 




On October 20, 2021, the FDA took additional actions on the use of a booster dose for 
COVID-19 Vaccines- the U.S. Food and Drug Administration took action to expand the 
use of a booster dose for COVID-19 vaccines in eligible populations. The agency is 
amending the emergency use authorizations (EUA) for COVID-19 vaccines to allow for 
the use of a single booster dose as follows: 
 
• The use of a single booster dose of the Moderna COVID-19 Vaccine that 
may be administered at least 6 months after completion of the primary 
series to individuals: 
o 65 years of age and older 
o 18 through 64 years of age at high risk of severe COVID-19 
o 18 through 64 years of age with frequent institutional or 
occupational exposure to SARS-CoV-2 
• The use of a single booster dose of the Janssen (Johnson and Johnson) 
COVID-19 Vaccine may be administered at least 2 months after 
completion of the single-dose primary regimen to individuals 18 years of 
age and older. 
• The use of each of the available COVID-19 vaccines as a heterologous 
(or “mix and match”) booster dose in eligible individuals following 
completion of primary vaccination with a different available COVID-19 
vaccine. 
• To clarify that a single booster dose of the Pfizer-BioNTech COVID-19 
Vaccine may be administered at least 6 months after completion of the 
primary series to individuals 18 through 64 years of age with frequent 





Vaccines and Related Biological Products Advisory Committee October 26, 2021 
(830AM-5PM) Meeting Announcement- The meeting presentations will be heard, viewed, 
captioned, and recorded through an online teleconferencing platform. The committee will 
meet in open session to discuss a request to amend Pfizer-BioNTech’s Emergency Use 
Authorization (EUA) for administration of their COVID-19 mRNA vaccine to children 5 













Centers for Disease Control and Prevention (CDC) 
On October 25, 2021, CDC Issues Orders Operationalizing the President’s Safer, More 
Stringent International Travel System- the Centers for Disease Control and Prevention 
(CDC) is issuing Orders to implement the new travel policy announced by the Biden 
administration to safely resume global travel to the United States while protecting the 
health and safety of American communities from COVID-19. These Orders put in place a 
stringent and consistent global international travel policy that is guided by public health. 
https://www.cdc.gov/media/releases/2021/p1025-International-Travel-System.html  
 
On October 22, 2021, the CDC provided updated guidance regarding Who Is Eligible for a 
COVID-19 Vaccine Booster Shot? CDC now recommends that certain people are now 
eligible to receive a COVID-19 booster shot, including those who received Moderna and 




On October 21, 2021, CDC Expands Eligibility for COVID-19 Booster Shots- CDC 
Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on 
Immunization Practices’ (ACIP) recommendation for a booster shot of COVID-19 vaccines 
in certain populations. The Food and Drug Administration’s (FDA) authorization and 
CDC’s recommendation for use are important steps forward as we work to stay ahead of 
the virus and keep Americans safe. 
https://www.cdc.gov/media/releases/2021/p1021-covid-booster.html  
 
CDC provides updated information about the variants in the United States- The emerging 
variants CDC is closely monitoring have mutations in the virus genome that alter the 
characteristics and cause the virus to act differently in ways that are significant to public 
health (e.g., causes more severe disease, spreads more easily between humans, 
requires different treatments, changes the effectiveness of current vaccines). It’s 
important to understand that genetic mutations are expected, and some variants can 
spread and become predominant while others subside. 
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html  
 
CDC provides daily data tracker which has maps and charts tracking cases, deaths, and 
trends of COVID-19 in the United States- updated daily by 8 p.m. ET. 
https://covid.cdc.gov/covid-data-tracker/#datatracker-home  
 
For the latest CDC information 
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/index.html 
 
Center for Medicare and Medicaid Services (CMS)  






In this section, vaccine-related information from various sources will be collected, 
reviewed, and tabulated here.  As of October 26, 2021, the FDA has granted Emergency 
Use Authorization (EUA) to Moderna and Janssen/Johnson & Johnson. On August 23, 
2021, the FDA granted full approval to Pfizer. Now with two vaccines with EUA and one 
vaccine with full FDA approval, the goal is to vaccinate a larger number of persons in the 
coming months throughout the United States. As additional vaccines are granted EUA, 
information for those vaccines will also be included. 
 
CDC created this section regarding COVID-19 vaccinations in the United States- CDC 
provides overall US COVID-19 Vaccine, deliveries and administration, maps, charts, and 
data updated daily by 8 p.m. This section represents all vaccine partners including 
jurisdictional partner clinics, retail pharmacies, long-term care facilities, Federal 
Emergency Management Agency and Health Resources and Services Administration 
partner sites, and federal entity facilities.  
https://covid.cdc.gov/covid-data-tracker/#vaccinations  
 
On October 25, 2021, at Binghamton University's Decker College of Nursing and Health 
Sciences, Governor Kathy Hochul received her COVID-19 vaccine booster shot and 
encouraged other eligible New Yorkers to do the same. Governor Hochul received the 




The NYS DOH COVID-19 Vaccine Tracker Dashboard will update New Yorkers on the 
distribution of the vaccine including the number of doses received by the state, a 
breakdown of first or second doses, and the number of persons vaccinated with the first 
and second doses in each region. 
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker  
 
CDC created this section regarding the Johnson & Johnson’s Janssen vaccine to provide 
updated relevant information including side effects and safety data, clinical trials 
demographic statistics, and information on how the vaccine works. 
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html  
 
CDC created this section regarding the Moderna vaccine to provide updated relevant 
information including side effects and safety data, clinical trials demographic statistics, 
and information on how the vaccine works. 
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html   
 
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated 
relevant information including side effects and safety data, clinical trials demographic 
statistics, and information on how the vaccine works. As of October 16, 2021, the fully 




HHS created this section to provide the latest information about COVID-19 vaccines. 
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html  
 
For NYC DOHMH updated guidance regarding COVID-19 vaccine 
https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page  
 
The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19 
vaccination location. The Vaccine Finder can also provide New Yorkers with information 




Educational Institution Information 
• Higher Education 
o Especially if trained to do so, faculty members should shift their mind-sets 
and become much more a part of students’ network of mental health 




o The nation's public school districts faced unprecedented disruption to the 
school year as the novel coronavirus pandemic shut down buildings and 
forced learning online, to the extent educators were able to do so. 
Shutdowns forced districts and policymakers alike to make strides in 
addressing the "homework gap" resulting from a lack of home internet 
and device access that already adversely affected many students prior to 
shutdowns. Further complicating the situation: Educators needed 
additional training, the delivery of curriculum had to be rethought, and 
many low-income students' only guaranteed meals throughout the day 
were through school programs. 
https://www.k12dive.com/news/tracking-how-the-coronavirus-is-
impacting-school-districts/578628/  
o Quarantine absence policies threaten state funding for California schools- 
Two overlapping attendance policies in California could contribute to a 
decline in funding for the state's schools. The state reverted to its pre-
pandemic average daily attendance policies for the 2021-22 school year, 
meaning schools will no longer use attendance from 2019-20 to calculate 
funding as in the previous academic year and will instead rely on average 







To view the latest information on clinical trials regarding COVID-19 
https://www.clinicaltrials.gov/ct2/results?recrs=&cond=Covid19&term=&cntry=&state=&cit
y=&dist=  











New York City 
• On October 25, 2021, Mayor DiBlasio held a media briefing regarding COVID-19 
response. During the media briefing, Mayor DiBlasio received his booster shot. 
https://www1.nyc.gov/office-of-the-mayor/news/710-21/transcript-mayor-de-blasio-holds-
media-availability  
• On October 20, 2201, Mayor Bill de Blasio announced a COVID-19 vaccination mandate 
for all City workers. Starting today, City employees will receive an extra $500 in their 
paycheck for receiving their first shot. This benefit will end at 5 p.m. on Friday, October 
29, by which point City employees are required to have proof of at least one dose. 
Unvaccinated employees will be placed on unpaid leave until they show proof of 




New York State Department of Health (DOH) 
 
On October 25, 2021, Governor Kathy Hochul updated New Yorkers on the state's progress 
combating COVID-19.  "The COVID-19 vaccine is readily available, free, and most importantly, 
it's effective - now, for those eligible, it is also important to get booster shots to ensure your 
vaccine is as efficient as possible," Governor Hochul said. "A year ago, we were not lucky 
enough to have a vaccine at our disposal, but now we have multiple. The vaccine is the best tool 
we have to work our way out of this pandemic and I encourage those who have not yet received 




On October 23, 2021, Governor Kathy Hochul signed legislation allowing employees facing 
potential layoff to petition employers to participate in a shared work program. Under this 
amendment to labor law, the majority of employees may submit a request for a shared work 
program in writing to the employer before the layoff or within 10 days of the layoff. The employer 
then has seven days to respond and is not required to implement the program. This is especially 
important for ensuring full groups of laid off workers are rehired when business returns to 








NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information 
regarding testing, cases, percentages, and fatalities across New York State. It also breaks down 










• On October 20, 2021, Governor Phil Murphy signed Executive Order No. 271, which 
requires new and potential state contractors to demonstrate that all of their employees 
who enter, work at, or provide services in any state agency location are fully vaccinated 
or otherwise undergo weekly testing. “This executive order will bring state contractors in 
line with the requirements set for all direct state employees,” said Governor Murphy. 
“Quite simply, we must ensure that everyone providing service to the people of New 
Jersey is being held to the same public health safety and standards.” 
https://nj.gov/governor/news/news/562021/approved/20211020c.shtml  




• As the State of Connecticut continues taking actions in response to the global spread of 
coronavirus disease (COVID-19), Governor Ned Lamont provided the following updates 
as of 4:00 p.m. on Monday, October 25, 2021: 
https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2021/10-
2021/Governor-Lamont-Coronavirus-Update-October-25  
• On October 22, 2021, Governor Lamont released updated data regarding compliance 
with the state’s COVID-19 vaccination and testing requirements among agencies in the 
State of Connecticut executive branch. Overall compliance remains high with 95 percent 
of employees fully vaccinated or current in their weekly testing. When including those 
who are temporarily out of compliance due to incomplete or late testing result 
submissions and are in the process of becoming compliant, that percentage increases to 
99 percent. The overall vaccination rate is currently 80.8 percent. That is an increase 





• For the most up-to-date information from the State of Connecticut on COVID-19, 
residents are encouraged to visit ct.gov/coronavirus.  Residents can also subscribe to 








Local Updates  
 
New York Blood Center (NYBC) 
 
For the latest updated NYBC information about COVID-19: 
https://nybc.org/covid-19/  
 
New York City (NYC) Department of Health and Mental Hygiene (DOHMH)   
 
NYC DOHMH launched a new variants data page. The data on this page show how variants of the 
virus that causes COVID-19 are spreading in NYC. Variants are versions of the virus with certain 
sets of mutations. Some variants may result in a COVID-19 infection that is easier to spread, more 
severe or able to avoid antibodies from vaccines or previous infections. 
https://www1.nyc.gov/site/doh/covid/covid-19-data-variants.page  
 
For NYC DOHMH updated COVID-19 data page 
https://www1.nyc.gov/site/doh/covid/covid-19-data.page  
 
For the latest COVID-19 information from NYC DOHMH 
https://www1.nyc.gov/site/doh/covid/covid-19-main.page  
 
Westchester County Department of Health 
  
For the latest breakdown of positive cases in Westchester County as of October 24, 2021 
https://wcgis.maps.arcgis.com/apps/dashboards/280339d96db14efd9cc304dba0f3a71d  
 
For the latest COVID-19 information in Westchester including how to avoid the latest vaccine scams 
offering earlier access to vaccines. 
https://health.westchestergov.com/2019-novel-coronavirus   
 
Putnam County Department of Health 
Breakdown of positive cases by towns in Putnam County as of October 21, 2021- 
https://www.putnamcountyny.com/covid19/  
 
For the latest COVID-19 information 
https://www.putnamcountyny.com/health/coronavirus/ 
 
Dutchess County Department of Health 
 
Breakdown of positive cases in Dutchess County as of October 25, 2021 
https://www.dutchessny.gov/Departments/DBCH/covid-19-dashboard.htm 
 
For the latest COVID-19 information: 
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm 
 
Orange County Department of Health   
 
Updated COVID-19 dashboard for Orange County as of October 25, 2021 
https://ocnygis.maps.arcgis.com/apps/dashboards/21de1fb5ce0c480f95dc0cf2b8b83b71 
 
For the latest COVID-19 information  
https://www.orangecountygov.com/1906/2019-Novel-Coronavirus-Information 
 
Rockland County Department of Health 
 
Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of 
October 25, 2021 
https://www.arcgis.com/apps/dashboards/d074e0336e81449393a76d1768ceb096  
 





For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital 




Center for Disaster Medicine Media 
 
New York Medical College News: 
NY Medical College receives state grant for Center for Disaster Medicine 




David S. Markenson, M.D., M.B.A., medical director, Center for Disaster Medicine 
Salomon Amar, D.D.S., Ph.D., vice president for research, NYMC, and senior vice president 
for research affairs, Touro College and University System 
Robert W. Amler, M.D., M.B.A., vice president of government affairs and dean of the School 
of Health Sciences and Practice 
Renee Garrick, M.D., vice dean and chief medical officer for Westchester Medical Center and 
professor of clinical medicine 







Every effort is made to provide accurate and complete information in this newsletter. However, New 
York Medical College cannot guarantee that there will be no errors. NYMC makes no claims, promises or 
guarantees about the accuracy, completeness, or adequacy of the contents of the newsletters or the 
articles linked herein and further expressly disclaims liability for errors and omissions in the contents of 
this newsletter.  
 
This newsletter is for informational purposes only; it does not constitute medical advice. Always seek the 







New York Medical College 
Center for Disaster Medicine 
7 Dana Road Suite 511 
Valhalla, New York 10595 
914-594-1750 
https://www.nymc.edu/center-for-disaster-medicine/ 
 
 
 
 
 
 
